loadpatents
Patent applications and USPTO patent grants for HAMLYN; Richard John.The latest application filed is for "potassium channel blockers".
Patent | Date |
---|---|
Potassium Channel Blockers App 20150259282 - MULLA; Mushtaq ;   et al. | 2015-09-17 |
Potassium channel blockers Grant 9,073,834 - Mulla , et al. July 7, 2 | 2015-07-07 |
Potassium Channel Blockers App 20140221337 - Mulla; Mushtaq ;   et al. | 2014-08-07 |
Potassium channel blockers Grant 8,673,901 - Mulla , et al. March 18, 2 | 2014-03-18 |
Compounds Grant 8,426,442 - Hamlyn , et al. April 23, 2 | 2013-04-23 |
Compounds Grant 8,399,481 - Hamlyn , et al. March 19, 2 | 2013-03-19 |
Potassium channel blockers Grant 8,372,840 - Hamlyn , et al. February 12, 2 | 2013-02-12 |
Potassium channel blockers Grant 8,258,138 - John , et al. September 4, 2 | 2012-09-04 |
Compounds App 20110136860 - Hamlyn; Richard John ;   et al. | 2011-06-09 |
Compounds App 20110136859 - HAMLYN; Richard John ;   et al. | 2011-06-09 |
New Potassium Channel Blockers App 20100087438 - HAMLYN; Richard John ;   et al. | 2010-04-08 |
Novel Potassium Channel Blockers App 20100087428 - Mulla; Mushtaq ;   et al. | 2010-04-08 |
Novel Potassium Channel Blockers App 20100087437 - JOHN; Derek Edward ;   et al. | 2010-04-08 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, Receptor ligands App 20080125455 - Roffey; Jonathan Richard Anthony ;   et al. | 2008-05-29 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands App 20080114018 - Roffey; Jonathan Richard Anthony ;   et al. | 2008-05-15 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands App 20080090858 - Roffey; Jonathan Richard Anthony ;   et al. | 2008-04-17 |
Condensed indoline derivatives and their use as 5-HT, in particular 5-HT.sub.2C, receptor ligands Grant 7,323,473 - Roffey , et al. January 29, 2 | 2008-01-29 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands Grant 7,323,487 - Roffey , et al. January 29, 2 | 2008-01-29 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands Grant 7,323,486 - Roffey , et al. January 29, 2 | 2008-01-29 |
Condensed indoline derivatives and their use as 5HT , in particular 5hHT2c, receptor ligands App 20070105889 - Roffey; Jonathan Richard Anthony ;   et al. | 2007-05-10 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands App 20070099980 - Roffey; Jonathan Richard Anthony ;   et al. | 2007-05-03 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands App 20070099981 - Roffey; Jonathan Richard Anthony ;   et al. | 2007-05-03 |
Azacyclic compounds as inhibitors of sensory neurone specific channels App 20070043024 - Hamlyn; Richard John ;   et al. | 2007-02-22 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands Grant 7,173,056 - Roffey , et al. February 6, 2 | 2007-02-06 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands Grant 7,166,632 - Roffey , et al. January 23, 2 | 2007-01-23 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT.sub.2c, receptor ligands Grant 7,166,613 - Roffey , et al. January 23, 2 | 2007-01-23 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT.sub.2C, receptor ligands Grant 6,962,939 - Roffey , et al. November 8, 2 | 2005-11-08 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands App 20050197380 - Roffey, Jonathan Richard Anthony ;   et al. | 2005-09-08 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands App 20050192334 - Roffey, Jonathan Richard Anthony ;   et al. | 2005-09-01 |
Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands App 20050187282 - Roffey, Jonathan Richard Anthony ;   et al. | 2005-08-25 |
Indole derivatives process for their preparation, pharmaceutical compositions containing them and their medicinal application Grant 6,706,750 - Bentley , et al. March 16, 2 | 2004-03-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.